Official Title: “Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers”

Purpose of the project is to examine the effectiveness of Reinforcement-Based Treatment (RBT) on drug abuse and psychosocial outcomes of iner city opiate abusers who have recently completed a brief detoxification.

Study Type: Interventional

Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment

Study Primary Completion Date: February 2007

Participants are randomized into one of 3-groups: 1) those receiving intensive behavioral therapy plus abstinence-contingent housing, 2) those receiving recovery housing alone, and 3) those receiving standard care (referrals to community providers). For the two groups receiving recovery housing, rent payment is provided for a period of 3 months, as long as the participant remains drug-free.

Intervention(s) in this Clinical Trial

• Behavioral: Reinforcement-Based Treatment
  • 3 group random assignment to receive, standard care, recovery housing alone, or recovery housing plus behavioral treatment

Arms, Groups and Cohorts in this Clinical Trial

• No Intervention: 1
  • Standard care following detoxification
• Active Comparator: 2
  • Recovery housing following detoxification
• Experimental: 3
  • Recovery housing plus counseling

Primary Measures

• Drug abstinence at follow-up
  • Time Frame: 1, 3 and 6 months
    Safety Issue?: No

Secondary Measures

• Rates of employment
  • Time Frame: 1, 3, and 6 months
    Safety Issue?: No

Inclusion Criteria:

• opiate dependent agree to live in recovery housing

Exclusion Criteria:

• acute psychiatric disorder pregnant over 65

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 65 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Overall Clinical Trial Officials and Contacts

Maxine Stitzer, Ph.D. Principal Investigator Johns Hopkins  

Information obtained from ClinicalTrials.gov on August 29, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00685620

Study ID Number: BPR010213-01

ClinicalTrials.gov Identifier: NCT00685620

Health Authority: United States: Federal Government